Position in ARVN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$26,482
+$23,366 QoQ
Shares Held
3,187
+984.0% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#154
of 201 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ARVN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ROYAL BANK OF CANADA holds $2,116,200,383 across 427 Biotechnology names. ARVN ranks #204 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IONS |
Ionis Pharmaceuticals Inc
|
6,182,479 | $490,208,754 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
980,259 | $486,924,048 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
875,859 | $263,659,830 | |
| 4 | INCY |
Incyte Corp
|
1,132,050 | $128,329,182 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
174,515 | $108,817,078 | |
| 6 | MRNA |
Moderna, Inc.
|
944,457 | $66,140,319 | |
| 7 | INSM |
INSMED Inc
|
416,487 | $44,405,840 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
545,761 | $42,716,712 |
All Filings in ARVN
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $26,482 | 3,187 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $3,116 | 294 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $22,331 | 1,883 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $1,551,994 | 182,159 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $464,643 | 63,131 | Shares | Defined | 2025-11-21 | |
| 2025-03-31 | $771 | 110 | Shares | Defined | 2025-11-21 | |
| 2024-12-31 | $25,246 | 1,317 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $182,655 | 7,416 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $184,023 | 6,913 | Shares | Defined | 2024-11-06 | |
| 2024-03-31 | $69,350 | 1,680 | Shares | Defined | 2024-11-05 | |
| 2023-12-31 | $680,703 | 16,538 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $139,639 | 7,110 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $99,428 | 4,006 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $131,325 | 4,807 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $409,902 | 11,982 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $54,722 | 1,230 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $37,627 | 894 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $231,781 | 3,444 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $896,721 | 10,917 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $352,798 | 4,293 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $230,153 | 2,989 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $142,842 | 2,161 | Shares | Defined | 2021-07-20 | |
| 2020-06-30 | $1,408 | 42 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $4,150 | 103 | Shares | Defined | 2020-06-16 | |
| No filing history on record for this holder in this stock. | ||||||